71 related articles for article (PubMed ID: 23144155)
1. Serum concentrations of human chorionic gonadotropin beta and its association with survival in patients with colorectal cancer.
Birgisson H; Jirström K; Stenman UH
Cancer Biomark; 2012; 11(4):173-81. PubMed ID: 23144155
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma.
Lyytinen I; Lempinen M; Nordin A; Mäkisalo H; Stenman UH; Isoniemi H
Scand J Gastroenterol; 2013 Sep; 48(9):1066-73. PubMed ID: 23889187
[TBL] [Abstract][Full Text] [Related]
3. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
Hotakainen K; Ljungberg B; Paju A; Rasmuson T; Alfthan H; Stenman UH
Br J Cancer; 2002 Jan; 86(2):185-9. PubMed ID: 11870503
[TBL] [Abstract][Full Text] [Related]
4. Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.
Hotakainen K; Ljungberg B; Haglund C; Nordling S; Paju A; Stenman UH
Int J Cancer; 2003 May; 104(5):631-5. PubMed ID: 12594819
[TBL] [Abstract][Full Text] [Related]
5. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
6. Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.
Louhimo J; Finne P; Alfthan H; Stenman UH; Haglund C
Anticancer Res; 2002; 22(3):1759-64. PubMed ID: 12168865
[TBL] [Abstract][Full Text] [Related]
7. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.
Lundin M; Nordling S; Carpelan-Holmstrom M; Louhimo J; Alfthan H; Stenman UH; Haglund C
Anticancer Res; 2000; 20(6D):4949-51. PubMed ID: 11326644
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma.
Riska A; Alfthan H; Finne P; Jalkanen J; Sorvari T; Stenman UH; Leminen A
Tumour Biol; 2006; 27(1):43-9. PubMed ID: 16340249
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.
Lundin M; Nordling S; Lundin J; Alfthan H; Stenman UH; Haglund C
Int J Cancer; 2001 Jan; 95(1):18-22. PubMed ID: 11241305
[TBL] [Abstract][Full Text] [Related]
10. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
[TBL] [Abstract][Full Text] [Related]
11. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.
Louhimo J; Alfthan H; Stenman UH; Haglund C
Oncology; 2004; 66(2):126-31. PubMed ID: 15138364
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.
Louhimo J; Kokkola A; Alfthan H; Stenman UH; Haglund C
Int J Cancer; 2004 Oct; 111(6):929-33. PubMed ID: 15300805
[TBL] [Abstract][Full Text] [Related]
14. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
17. Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
Ytting H; Christensen IJ; Thiel S; Jensenius JC; Nielsen HJ
Hum Immunol; 2008 Jul; 69(7):414-20. PubMed ID: 18638656
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum concentration of hCGbeta as a prognostic factor in ovarian cancer.
Vartiainen J; Lehtovirta P; Finne P; Stenman UH; Alfthan H
Int J Cancer; 2001 Sep; 95(5):313-6. PubMed ID: 11494231
[TBL] [Abstract][Full Text] [Related]
20. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
